Abstract
As the laryngopharynx is closely related to swallowing, speech, and phonation, it is necessary to consider not only disease control but also a minimally invasive approach for the treatment of laryngopharyngeal cancer. Transoral surgery has been reported to be a minimally invasive method for treating these diseases. Transoral videolaryngoscopic surgery (TOVS) and endoscopic laryngo-pharyngeal surgery (ELPS) have been developed in Japan and recently emerged as treatments for patients with early stage pharyngeal and laryngeal cancers. However, securing an appropriate field of view and a narrow operating space during TOVS or ELPS are critical issues to be resolved for these surgeries. The clinical significance and safety of transoral robotic surgery (TORS) using the da Vinci Surgical System have been widely reported to provide surgeons with increased visualization and magnification, resulting in precise surgical margins and rapid functional recovery. In this context, a multi-institutional clinical study was conducted to evaluate the treatment outcomes of TORS for the treatment of laryngopharyngeal cancer in Japan, and the da Vinci Surgical System for oral robot-assisted surgery for these diseases was approved by the Pharmaceutical Affairs Agency in August 2018. This review provides an overview of the therapeutic effects of TOVS, ELPS, and TORS, with a particular focus on these therapeutic results in Japan.
Highlights
Since the pharynx and larynx play an important role in swallowing, vocalization, and breathing, it is necessary to consider the quality of life (QoL) of patients after treatment for pharyngeal and laryngeal cancer
We address the current status and therapeutic efficacies of transoral surgeries for patients with early stage pharyngeal and laryngeal cancers, including transoral videolaryngoscopic surgery (TOVS), endoscopic laryngo-pharyngeal surgery (ELPS), and transoral robotic surgery (TORS)
The TOVS procedure was established to overcome the disadvantages of Transoral laser microsurgery (TLM), whereas ELPS was developed based on the endoscopic submucosal dissection (ESD) procedure for early esophageal cancer to resect superficial mucosal lesions of the pharynx or larynx transorally developed by Satou et al [5]
Summary
Received: 29 October 2021 Accepted: 22 November 2021 Published: 14 December 2021. Citation: Sano D, Shimizu A, Tateya I, Fujiwara K, Kishimoto Y, Maruo T, Fujimoto Y, Mori T, Kato H, Tsukahara K and Oridate N (2021) Current Status of Transoral Surgery for Patients With Early-Stage Pharyngeal and Laryngeal Cancers in Japan. The clinical significance and safety of transoral robotic surgery (TORS) using the da Vinci Surgical System have been widely reported to provide surgeons with increased visualization and magnification, resulting in precise surgical margins and rapid functional recovery. In this context, a multi-institutional clinical study was conducted to evaluate the treatment outcomes of TORS for the treatment of laryngopharyngeal cancer in Japan, and the da Vinci Surgical System for oral robot-assisted surgery for these diseases was approved by the Pharmaceutical Affairs Agency in August 2018.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
